(Total Views: 616)
Posted On: 04/17/2018 10:31:37 AM
Post# of 75347
CBD News --
Ad Com Thursday for GW Pharma's cannabidiol oral solution for types of epilepsy; shares up 11%
The FDA's Peripheral and Central Nervous System Drugs Advisory Committee will meet on Thursday, April 19, to discuss GW Pharmaceuticals' (GWPH +10.8%) marketing application seeking approval for its cannabidiol oral solution for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome or Dravet syndrome in patients at least two years old.
Ad Com Thursday for GW Pharma's cannabidiol oral solution for types of epilepsy; shares up 11%
The FDA's Peripheral and Central Nervous System Drugs Advisory Committee will meet on Thursday, April 19, to discuss GW Pharmaceuticals' (GWPH +10.8%) marketing application seeking approval for its cannabidiol oral solution for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome or Dravet syndrome in patients at least two years old.
(12)
(0)
